APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Sevoflurane For Inhalation

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sevoflurane For Inhalation Industry Growth and Trends Forecast to 2032

Report ID 174034930122 December 202596 pages

Choose your research edition.

Industry ResearchSevoflurane For Inhalation Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Sevoflurane For Inhalation Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Sevoflurane For Inhalation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sevoflurane For Inhalation Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Sevoflurane For Inhalation Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Sevoflurane For Inhalation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sevoflurane For Inhalation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sevoflurane For Inhalation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sevoflurane For Inhalation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sevoflurane For Inhalation include Hengrui, Lunan Pharma, Baxter, AbbVie, Viatris, PT Novell Pharmaceutical, Piramal and Maruishi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sevoflurane For Inhalation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sevoflurane For Inhalation market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sevoflurane For Inhalation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sevoflurane For Inhalation.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sevoflurane For Inhalation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sevoflurane For Inhalation Market by Company

Hengrui

Lunan Pharma

Baxter

AbbVie

Viatris

PT Novell Pharmaceutical

Piramal

Maruishi

Sevoflurane For Inhalation Segment by Type

250ml/Bottle

120ml/Bottle

Other

Sevoflurane For Inhalation Segment by Application

Hospital

Clinics

Other

Sevoflurane For Inhalation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sevoflurane For Inhalation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sevoflurane For Inhalation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sevoflurane For Inhalation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sevoflurane For Inhalation manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sevoflurane For Inhalation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 250ml/Bottle Table 2. Major Company of 120ml/Bottle Table 3. Major Company of Other Table 4. Global Sevoflurane For Inhalation Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Sevoflurane For Inhalation Sales by Type (2021-2026) & (k units) Table 6. Global Sevoflurane For Inhalation Sales Market Share in Volume by Type (2021-2026) Table 7. Global Sevoflurane For Inhalation Sales by Type (2021-2026) & (US$ Million) Table 8. Global Sevoflurane For Inhalation Sales Market Share in Value by Type (2021-2026) Table 9. Global Sevoflurane For Inhalation Price by Type (2021-2026) & (US$/unit) Table 10. Global Sevoflurane For Inhalation Sales by Type (2027-2032) & (k units) Table 11. Global Sevoflurane For Inhalation Sales Market Share in Volume by Type (2027-2032) Table 12. Global Sevoflurane For Inhalation Sales by Type (2027-2032) & (US$ Million) Table 13. Global Sevoflurane For Inhalation Sales Market Share in Value by Type (2027-2032) Table 14. Global Sevoflurane For Inhalation Price by Type (2027-2032) & (US$/unit) Table 15. North America Sevoflurane For Inhalation Sales by Type (2021-2026) & (k units) Table 16. North America Sevoflurane For Inhalation Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Sevoflurane For Inhalation Sales by Type (2021-2026) & (k units) Table 18. Europe Sevoflurane For Inhalation Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Sevoflurane For Inhalation Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Sevoflurane For Inhalation Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Sevoflurane For Inhalation Sales by Type (2021-2026) & (k units) Table 22. Latin America Sevoflurane For Inhalation Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Sevoflurane For Inhalation Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Sevoflurane For Inhalation Sales by Type (2021-2026) & (US$ Million) Table 25. Sevoflurane For Inhalation Industry Trends Table 26. Sevoflurane For Inhalation Industry Drivers Table 27. Sevoflurane For Inhalation Industry Opportunities and Challenges Table 28. Sevoflurane For Inhalation Industry Restraints Table 29. Global Sevoflurane For Inhalation Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Sevoflurane For Inhalation Revenue Market Share by Company (2021-2026) Table 31. Global Sevoflurane For Inhalation Sales by Company (2021-2026) & (k units) Table 32. Global Sevoflurane For Inhalation Sales Share by Company (2021-2026) Table 33. Global Sevoflurane For Inhalation Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Sevoflurane For Inhalation Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Sevoflurane For Inhalation Major Company Production Sites and Headquarters Table 36. Global Sevoflurane For Inhalation Company, Product Type & Application Table 37. Global Sevoflurane For Inhalation Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Sevoflurane For Inhalation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Sevoflurane For Inhalation Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Sevoflurane For Inhalation Sales by Region (2021-2026) & (k units) Table 42. Global Sevoflurane For Inhalation Sales Market Share in Volume by Region (2021-2026) Table 43. Global Sevoflurane For Inhalation Sales by Region (2021-2026) & (US$ Million) Table 44. Global Sevoflurane For Inhalation Sales Market Share in Value by Region (2021-2026) Table 45. Global Sevoflurane For Inhalation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Sevoflurane For Inhalation Sales by Region (2027-2032) & (k units) Table 47. Global Sevoflurane For Inhalation Sales Market Share in Volume by Region (2027-2032) Table 48. Global Sevoflurane For Inhalation Sales by Region (2027-2032) & (US$ Million) Table 49. Global Sevoflurane For Inhalation Sales Market Share in Value by Region (2027-2032) Table 50. Global Sevoflurane For Inhalation Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Sevoflurane For Inhalation Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Sevoflurane For Inhalation Sales by Application (2021-2026) & (k units) Table 53. Global Sevoflurane For Inhalation Sales Market Share in Volume by Application (2021-2026) Table 54. Global Sevoflurane For Inhalation Sales by Application (2021-2026) & (US$ Million) Table 55. Global Sevoflurane For Inhalation Sales Market Share in Value by Application (2021-2026) Table 56. Global Sevoflurane For Inhalation Price by Application (2021-2026) & (US$/unit) Table 57. Global Sevoflurane For Inhalation Sales by Application (2027-2032) & (k units) Table 58. Global Sevoflurane For Inhalation Sales Market Share in Volume by Application (2027-2032) Table 59. Global Sevoflurane For Inhalation Sales by Application (2027-2032) & (US$ Million) Table 60. Global Sevoflurane For Inhalation Sales Market Share in Value by Application (2027-2032) Table 61. Global Sevoflurane For Inhalation Price by Application (2027-2032) & (US$/unit) Table 62. North America Sevoflurane For Inhalation Sales by Application (2021-2026) & (k units) Table 63. North America Sevoflurane For Inhalation Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Sevoflurane For Inhalation Sales by Application (2021-2026) & (k units) Table 65. Europe Sevoflurane For Inhalation Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Sevoflurane For Inhalation Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Sevoflurane For Inhalation Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Sevoflurane For Inhalation Sales by Application (2021-2026) & (k units) Table 69. Latin America Sevoflurane For Inhalation Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Sevoflurane For Inhalation Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Sevoflurane For Inhalation Sales by Application (2021-2026) & (US$ Million) Table 72. Hengrui Company Information Table 73. Hengrui Business Overview Table 74. Hengrui Sevoflurane For Inhalation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Hengrui Sevoflurane For Inhalation Product Portfolio Table 76. Hengrui Recent Development Table 77. Lunan Pharma Company Information Table 78. Lunan Pharma Business Overview Table 79. Lunan Pharma Sevoflurane For Inhalation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Lunan Pharma Sevoflurane For Inhalation Product Portfolio Table 81. Lunan Pharma Recent Development Table 82. Baxter Company Information Table 83. Baxter Business Overview Table 84. Baxter Sevoflurane For Inhalation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Baxter Sevoflurane For Inhalation Product Portfolio Table 86. Baxter Recent Development Table 87. AbbVie Company Information Table 88. AbbVie Business Overview Table 89. AbbVie Sevoflurane For Inhalation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. AbbVie Sevoflurane For Inhalation Product Portfolio Table 91. AbbVie Recent Development Table 92. Viatris Company Information Table 93. Viatris Business Overview Table 94. Viatris Sevoflurane For Inhalation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Viatris Sevoflurane For Inhalation Product Portfolio Table 96. Viatris Recent Development Table 97. PT Novell Pharmaceutical Company Information Table 98. PT Novell Pharmaceutical Business Overview Table 99. PT Novell Pharmaceutical Sevoflurane For Inhalation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. PT Novell Pharmaceutical Sevoflurane For Inhalation Product Portfolio Table 101. PT Novell Pharmaceutical Recent Development Table 102. Piramal Company Information Table 103. Piramal Business Overview Table 104. Piramal Sevoflurane For Inhalation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Piramal Sevoflurane For Inhalation Product Portfolio Table 106. Piramal Recent Development Table 107. Maruishi Company Information Table 108. Maruishi Business Overview Table 109. Maruishi Sevoflurane For Inhalation Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Maruishi Sevoflurane For Inhalation Product Portfolio Table 111. Maruishi Recent Development Table 112. North America Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 113. North America Sevoflurane For Inhalation Sales by Country (2021-2026) & (k units) Table 114. North America Sevoflurane For Inhalation Sales Market Share by Country (2021-2026) Table 115. North America Sevoflurane For Inhalation Sales Forecast by Country (2027-2032) & (k units) Table 116. North America Sevoflurane For Inhalation Sales Market Share Forecast by Country (2027-2032) Table 117. North America Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. North America Sevoflurane For Inhalation Market Size by Country (2021-2026) & (US$ Million) Table 119. North America Sevoflurane For Inhalation Market Share by Country (2021-2026) Table 120. North America Sevoflurane For Inhalation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. North America Sevoflurane For Inhalation Market Share Forecast by Country (2027-2032) Table 122. Europe Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 123. Europe Sevoflurane For Inhalation Sales by Country (2021-2026) & (k units) Table 124. Europe Sevoflurane For Inhalation Sales Market Share by Country (2021-2026) Table 125. Europe Sevoflurane For Inhalation Sales Forecast by Country (2027-2032) & (k units) Table 126. Europe Sevoflurane For Inhalation Sales Market Share Forecast by Country (2027-2032) Table 127. Europe Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Europe Sevoflurane For Inhalation Market Size by Country (2021-2026) & (US$ Million) Table 129. Europe Sevoflurane For Inhalation Market Share by Country (2021-2026) Table 130. Europe Sevoflurane For Inhalation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Europe Sevoflurane For Inhalation Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Sevoflurane For Inhalation Sales by Country (2021-2026) & (k units) Table 134. Asia-Pacific Sevoflurane For Inhalation Sales Market Share by Country (2021-2026) Table 135. Asia-Pacific Sevoflurane For Inhalation Sales Forecast by Country (2027-2032) & (k units) Table 136. Asia-Pacific Sevoflurane For Inhalation Sales Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Sevoflurane For Inhalation Market Size by Country (2021-2026) & (US$ Million) Table 139. Asia-Pacific Sevoflurane For Inhalation Market Share by Country (2021-2026) Table 140. Asia-Pacific Sevoflurane For Inhalation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Asia-Pacific Sevoflurane For Inhalation Market Share Forecast by Country (2027-2032) Table 142. Latin America Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Latin America Sevoflurane For Inhalation Sales by Country (2021-2026) & (k units) Table 144. Latin America Sevoflurane For Inhalation Sales Market Share by Country (2021-2026) Table 145. Latin America Sevoflurane For Inhalation Sales Forecast by Country (2027-2032) & (k units) Table 146. Latin America Sevoflurane For Inhalation Sales Market Share Forecast by Country (2027-2032) Table 147. Latin America Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Latin America Sevoflurane For Inhalation Market Size by Country (2021-2026) & (US$ Million) Table 149. Latin America Sevoflurane For Inhalation Market Share by Country (2021-2026) Table 150. Latin America Sevoflurane For Inhalation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Latin America Sevoflurane For Inhalation Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Sevoflurane For Inhalation Sales by Country (2021-2026) & (k units) Table 154. Middle East and Africa Sevoflurane For Inhalation Sales Market Share by Country (2021-2026) Table 155. Middle East and Africa Sevoflurane For Inhalation Sales Forecast by Country (2027-2032) & (k units) Table 156. Middle East and Africa Sevoflurane For Inhalation Sales Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Sevoflurane For Inhalation Market Size by Country (2021-2026) & (US$ Million) Table 159. Middle East and Africa Sevoflurane For Inhalation Market Share by Country (2021-2026) Table 160. Middle East and Africa Sevoflurane For Inhalation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Middle East and Africa Sevoflurane For Inhalation Market Share Forecast by Country (2027-2032) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Sevoflurane For Inhalation Distributors List Table 165. Sevoflurane For Inhalation Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Sevoflurane For Inhalation Image Figure 2. Global Sevoflurane For Inhalation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sevoflurane For Inhalation Market Size (2021-2032) & (US$ Million) Figure 4. Global Sevoflurane For Inhalation Sales (2021-2032) & (k units) Figure 5. 250ml/Bottle Image Figure 6. Global 250ml/Bottle Sales YoY Growth (2021-2032) & (k units) Figure 7. 120ml/Bottle Image Figure 8. Global 120ml/Bottle Sales YoY Growth (2021-2032) & (k units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Sevoflurane For Inhalation Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Sevoflurane For Inhalation Market Share by Type 2025 VS 2032 Figure 13. North America Sevoflurane For Inhalation Sales Market Share in Volume by Type in 2025 Figure 14. North America Sevoflurane For Inhalation Sales Market Share in Value by Type in 2025 Figure 15. Europe Sevoflurane For Inhalation Sales Market Share in Volume by Type in 2025 Figure 16. Europe Sevoflurane For Inhalation Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Sevoflurane For Inhalation Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Sevoflurane For Inhalation Sales Market Share in Value by Type in 2025 Figure 19. Latin America Sevoflurane For Inhalation Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Sevoflurane For Inhalation Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Sevoflurane For Inhalation Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Sevoflurane For Inhalation Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Sevoflurane For Inhalation Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Sevoflurane For Inhalation Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Sevoflurane For Inhalation Market Share by Application 2025 VS 2032 Figure 33. North America Sevoflurane For Inhalation Sales Market Share in Volume by Application in 2025 Figure 34. North America Sevoflurane For Inhalation Sales Market Share in Value by Application in 2025 Figure 35. Europe Sevoflurane For Inhalation Sales Market Share in Volume by Application in 2025 Figure 36. Europe Sevoflurane For Inhalation Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Sevoflurane For Inhalation Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Sevoflurane For Inhalation Sales Market Share in Value by Application in 2025 Figure 39. Latin America Sevoflurane For Inhalation Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Sevoflurane For Inhalation Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Sevoflurane For Inhalation Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Sevoflurane For Inhalation Sales Market Share in Value by Application in 2025 Figure 43. North America Sevoflurane For Inhalation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Sevoflurane For Inhalation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Sevoflurane For Inhalation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Sevoflurane For Inhalation Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Sevoflurane For Inhalation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Sevoflurane For Inhalation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Sevoflurane For Inhalation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Sevoflurane For Inhalation Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Sevoflurane For Inhalation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Sevoflurane For Inhalation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Sevoflurane For Inhalation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Sevoflurane For Inhalation Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Sevoflurane For Inhalation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Sevoflurane For Inhalation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Sevoflurane For Inhalation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Sevoflurane For Inhalation Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Sevoflurane For Inhalation Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Sevoflurane For Inhalation Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Sevoflurane For Inhalation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Sevoflurane For Inhalation Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Sevoflurane For Inhalation Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Sevoflurane For Inhalation Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 250ml/Bottle
  • 120ml/Bottle
  • Other
Applications
  • Hospital
  • Clinics
  • Other
Companies covered
  • Hengrui
  • Lunan Pharma
  • Baxter
  • AbbVie
  • Viatris
  • PT Novell Pharmaceutical
  • Piramal
  • Maruishi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sevoflurane For Inhalation Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sevoflurane For Inhalation Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sevoflurane For Inhalation Market by Type
  6. 1.3.1 250ml/Bottle
  7. 1.3.2 120ml/Bottle
  8. 1.3.3 Other
  9. 1.4 Global Sevoflurane For Inhalation Market Size by Type
  10. 1.4.1 Global Sevoflurane For Inhalation Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Sevoflurane For Inhalation Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Sevoflurane For Inhalation Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Sevoflurane For Inhalation Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Sevoflurane For Inhalation Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Sevoflurane For Inhalation Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Sevoflurane For Inhalation Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Sevoflurane For Inhalation Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sevoflurane For Inhalation Industry Trends
  2. 2.2 Sevoflurane For Inhalation Industry Drivers
  3. 2.3 Sevoflurane For Inhalation Industry Opportunities and Challenges
  4. 2.4 Sevoflurane For Inhalation Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sevoflurane For Inhalation Revenue (2021-2026)
  2. 3.2 Global Top Players by Sevoflurane For Inhalation Sales (2021-2026)
  3. 3.3 Global Top Players by Sevoflurane For Inhalation Price (2021-2026)
  4. 3.4 Global Sevoflurane For Inhalation Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sevoflurane For Inhalation Major Company Production Sites & Headquarters
  6. 3.6 Global Sevoflurane For Inhalation Company, Product Type & Application
  7. 3.7 Global Sevoflurane For Inhalation Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sevoflurane For Inhalation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sevoflurane For Inhalation Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sevoflurane For Inhalation Tier 1, Tier 2, and Tier 3
4 Sevoflurane For Inhalation Regional Status and Outlook
  1. 4.1 Global Sevoflurane For Inhalation Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sevoflurane For Inhalation Historic Market Size by Region
  3. 4.2.1 Global Sevoflurane For Inhalation Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sevoflurane For Inhalation Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sevoflurane For Inhalation Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sevoflurane For Inhalation Forecasted Market Size by Region
  7. 4.3.1 Global Sevoflurane For Inhalation Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sevoflurane For Inhalation Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sevoflurane For Inhalation Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sevoflurane For Inhalation by Application
  1. 5.1 Sevoflurane For Inhalation Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global Sevoflurane For Inhalation Market Size by Application
  6. 5.2.1 Global Sevoflurane For Inhalation Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Sevoflurane For Inhalation Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Sevoflurane For Inhalation Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Sevoflurane For Inhalation Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Sevoflurane For Inhalation Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Sevoflurane For Inhalation Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Sevoflurane For Inhalation Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Sevoflurane For Inhalation Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hengrui
  2. 6.1.1 Hengrui Company Information
  3. 6.1.2 Hengrui Business Overview
  4. 6.1.3 Hengrui Sevoflurane For Inhalation Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hengrui Sevoflurane For Inhalation Product Portfolio
  6. 6.1.5 Hengrui Recent Developments
  7. 6.2 Lunan Pharma
  8. 6.2.1 Lunan Pharma Company Information
  9. 6.2.2 Lunan Pharma Business Overview
  10. 6.2.3 Lunan Pharma Sevoflurane For Inhalation Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Lunan Pharma Sevoflurane For Inhalation Product Portfolio
  12. 6.2.5 Lunan Pharma Recent Developments
  13. 6.3 Baxter
  14. 6.3.1 Baxter Company Information
  15. 6.3.2 Baxter Business Overview
  16. 6.3.3 Baxter Sevoflurane For Inhalation Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baxter Sevoflurane For Inhalation Product Portfolio
  18. 6.3.5 Baxter Recent Developments
  19. 6.4 AbbVie
  20. 6.4.1 AbbVie Company Information
  21. 6.4.2 AbbVie Business Overview
  22. 6.4.3 AbbVie Sevoflurane For Inhalation Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AbbVie Sevoflurane For Inhalation Product Portfolio
  24. 6.4.5 AbbVie Recent Developments
  25. 6.5 Viatris
  26. 6.5.1 Viatris Company Information
  27. 6.5.2 Viatris Business Overview
  28. 6.5.3 Viatris Sevoflurane For Inhalation Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Viatris Sevoflurane For Inhalation Product Portfolio
  30. 6.5.5 Viatris Recent Developments
  31. 6.6 PT Novell Pharmaceutical
  32. 6.6.1 PT Novell Pharmaceutical Company Information
  33. 6.6.2 PT Novell Pharmaceutical Business Overview
  34. 6.6.3 PT Novell Pharmaceutical Sevoflurane For Inhalation Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 PT Novell Pharmaceutical Sevoflurane For Inhalation Product Portfolio
  36. 6.6.5 PT Novell Pharmaceutical Recent Developments
  37. 6.7 Piramal
  38. 6.7.1 Piramal Company Information
  39. 6.7.2 Piramal Business Overview
  40. 6.7.3 Piramal Sevoflurane For Inhalation Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Piramal Sevoflurane For Inhalation Product Portfolio
  42. 6.7.5 Piramal Recent Developments
  43. 6.8 Maruishi
  44. 6.8.1 Maruishi Company Information
  45. 6.8.2 Maruishi Business Overview
  46. 6.8.3 Maruishi Sevoflurane For Inhalation Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Maruishi Sevoflurane For Inhalation Product Portfolio
  48. 6.8.5 Maruishi Recent Developments
7 North America by Country
  1. 7.1 North America Sevoflurane For Inhalation Sales by Country
  2. 7.1.1 North America Sevoflurane For Inhalation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sevoflurane For Inhalation Sales by Country (2021-2026)
  4. 7.1.3 North America Sevoflurane For Inhalation Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sevoflurane For Inhalation Market Size by Country
  6. 7.2.1 North America Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sevoflurane For Inhalation Market Size by Country (2021-2026)
  8. 7.2.3 North America Sevoflurane For Inhalation Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sevoflurane For Inhalation Sales by Country
  2. 8.1.1 Europe Sevoflurane For Inhalation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sevoflurane For Inhalation Sales by Country (2021-2026)
  4. 8.1.3 Europe Sevoflurane For Inhalation Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sevoflurane For Inhalation Market Size by Country
  6. 8.2.1 Europe Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sevoflurane For Inhalation Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sevoflurane For Inhalation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sevoflurane For Inhalation Sales by Country
  2. 9.1.1 Asia-Pacific Sevoflurane For Inhalation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sevoflurane For Inhalation Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sevoflurane For Inhalation Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sevoflurane For Inhalation Market Size by Country
  6. 9.2.1 Asia-Pacific Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sevoflurane For Inhalation Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sevoflurane For Inhalation Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sevoflurane For Inhalation Sales by Country
  2. 10.1.1 South America Sevoflurane For Inhalation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sevoflurane For Inhalation Sales by Country (2021-2026)
  4. 10.1.3 South America Sevoflurane For Inhalation Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sevoflurane For Inhalation Market Size by Country
  6. 10.2.1 South America Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sevoflurane For Inhalation Market Size by Country (2021-2026)
  8. 10.2.3 South America Sevoflurane For Inhalation Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sevoflurane For Inhalation Sales by Country
  2. 11.1.1 Middle East and Africa Sevoflurane For Inhalation Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sevoflurane For Inhalation Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sevoflurane For Inhalation Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sevoflurane For Inhalation Market Size by Country
  6. 11.2.1 Middle East and Africa Sevoflurane For Inhalation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sevoflurane For Inhalation Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sevoflurane For Inhalation Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sevoflurane For Inhalation Value Chain Analysis
  2. 12.1.1 Sevoflurane For Inhalation Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sevoflurane For Inhalation Production Mode & Process
  7. 12.2 Sevoflurane For Inhalation Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sevoflurane For Inhalation Distributors
  10. 12.2.3 Sevoflurane For Inhalation Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst